Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Oct 1996, 2356-2363, Vol 34, No. 10
G Funke, RA Hutson, KA Bernard, GE Pfyffer, G Wauters and MD Collins
Arthrobacter spp. are very widely distributed in the environment (e.g.,
soil) but have not been described as causing disease in humans. Over a
6-year period, two reference laboratories isolated or received 11 strains
which were eventually identified as belonging to the genus Arthrobacter.
These strains had been initially identified as Centers for Disease Control
and Prevention coryneform group B-1 and B-3 bacteria (whitishgrayish
colonies of 2 mm or greater in diameter after 24 h of incubation,
respiratory metabolism, absent or weak acid production from sugars, and
hydrolysis of gelatin). However, chemotaxonomic investigations revealed
lysine as the diamino acid of the cell wall and the presence of branched
cellular fatty acids (with anteiso-pentadecanoic acid predominating) which
was compatible with an assignment of the 11 isolates to the genus
Arthrobacter only. Peptidoglycan and 16S rRNA gene sequence analyses
demonstrated that three of the strains studied were representatives of a
new Arthrobacter species for which the name Arthrobacter cumminsii sp. nov.
is proposed and that one other strain represented a second new Arthrobacter
species for which the name Arthrobacter woluwensis sp. nov. is proposed.
This report is the first on the isolation of Arthrobacter spp. from
clinical specimens.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Isolation of Arthrobacter spp. from clinical specimens and description of Arthrobacter cumminsii sp. nov. and Arthrobacter woluwensis sp. nov
Department of Medical Microbiology, University of Zurich, Switzerland.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»